Toni Stifano, Office of Compliance, Promotion and Advertising Policy Staff, CDRH, FDA
Bryant Godfrey, J.D., M.H.A., Senior Lead Regulatory Counsel, Office of Prescription Drug Promotion, FDA
Cynthia Ng, JD, Regulatory Counsel, FDA
Janet L. "Lucy" Rose, MBA, President, Lucy Rose and Associates, LLC
Paul J. Savidge, JD, MBA,
Vice President & Associate General Counsel,, Regulatory/Commercial Law, Bristol-Myers Squibb Co.
Michele Sharp, PharmD,
Senior Director, Global Regulatory Affairs – US, Eli Lilly and Company
Thomas W. Abrams, MBA, RPh,
Director, Office of Prescription Drug Promotion, CDER, FDA
Lisa L. Stockbridge, PhD,
Branch Chief, Advertising and Promotional Labeling Branch,CBER, FDA
Introduction/Discussion, Vice President/Group Director, Regulatory Review, Digitas Health
Edwin J Tucker, BSc, MB, ChB, DPM, MRCP, MBA,
VP, Head of PV Operations, Global Medical Safety, Janssen Research & Development
Leah Palmer, PharmD,
Executive Director, Regulatory Promotions, Amgen Inc.
Worldwide Director, Regulatory Affairs, Life Scan, Inc.
Dan J. Halberstadt, RPh,
Senior Director, US Medical Communications & Knowledge Management, Global Medical Affairs, Shire SP
Kinsey S .Reagan, Esq.
Partner, Kleinfeld, Kaplan and Becker, LLP
Deborah Wolf, JD, Regulatory Counsel, Offi ce of Compliance, CDRH, FDA
Zafar Toor, PharmD, Director, Commercial Regulatory Affairs, Regulatory Core Functional Unit, Eisai Product Creation Systems
William A. Sarraille, Partner , Sidley Austin, LLP
Kris Curry, Vice President, Health Care Compliance, Pharmaceuticals Group, Johnson & Johnson
Robert J. Matheis, PhD, Senior Director, CER Communications, Evidence Based Medicine Sanofi
Michael S. Labson, JD, Partner, Covington & Burling LLP
Glenn N. Byrd, MBA, RAC, Senior Director, Regulatory Affairs, MedImmune, LLC
Bryant Lim, JD, Associate General Counsel, ViroPharma Incorporated